Author:
Xiao Z,Li L,Li Y,Zhou W,Cheng J,Liu F,Zheng P,Zhang Y,Che Y
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference41 articles.
1. Bustinza-Linares E, Kurzrock R, Tsimberidou AM . Salirasib in the treatment of pancreatic cancer. Future Oncol 2010; 6: 885–891.
2. Abbruzzese JL . New applications of gemcitabine and future directions in the management of pancreatic cancer. Cancer 2002; 95: 941–945.
3. Yip-Schneider MT, Sweeney CJ, Jung SH, Crowell PL, Marshall MS . Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther 2001; 298: 976–985.
4. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA . Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006; 20: 1218–1249.
5. Talar-Wojnarowska R, Malecka-Panas E . Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications. Med Sci Monit 2006; 12: RA186–RA193.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献